GaryFanjiangMDMBA, MS
Pediatric Gastroenterology • Wilmington, DEDivisional Vice President, Scientific & Medical Affairs, Abbott Nutrition
Dr. Fanjiang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Concord Pike
Wilmington, DE 19897
Education & Training
Boston Children’s HospitalResidency, Peds/Psych/Child-Adolescent Psych, 2000 - 2002
Tufts University School of MedicineClass of 2000
Certifications & Licensure
DE State Medical License 2007 - 2025
MA State Medical License 2004 - 2007
Publications & Presentations
PubMed
- 15 citationsComparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritisMark C. Genovese, Juan Sánchez-Bursón, MyungShin Oh, Éva Balázs, Jeffrey Neal
Arthritis Research & Therapy. 2020-03-26 - 7 citationsPharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single-Blind, Single-Dose, Parallel-Group Study in Healthy Subje...Vincent Chow, MyungShin Oh, Melissa A. Gessner, Gary Fanjiang
Clinical Pharmacology in Drug Development. 2019-10-19 - 22 citationsA Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501Richard Markus, Helen J. McBride, Monica Ramchandani, Vincent Chow, Jennifer Liu
Advances in Therapy. 2019-06-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
